Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial : clinical research : heart failure and cardiomyopathies - Döhner, Wolfram; Anker, Stefan D; Butler, Javed; Zannad, Faiez; Filippatos, Gerasimos; Ferreira, João Pedro; Salsali, Afshin; Kaempfer, Carolyn; Brückmann, Martina; Pocock, Stuart J; Januzzi, James L; Packer, Milton (European heart journal, 2022)
Gesehen am 18.09.2023